Boundless Bio BOLD
NASDAQ BOLD
$2.56 +0.05 (+1.77%)
As of: Oct 1, 2026 · 1:02 PM EDT

Boundless Bio (BOLD) Cash from Financing Activities (2023 - 2025)

Updated

Boundless Bio's Cash from Financing Activities was $24,000 in Q4 2025, down 78.8% from $113,000 a year earlier.

Analysis

Boundless Bio (BOLD) Cash from Financing Activities (2023 - 2025) Analysis & Trends

For FY2025, Cash from Financing Activities at Boundless Bio came in at $141,000, down 99.8% from FY2024.

  • In earlier years, Cash from Financing Activities was $89.82 million in FY2024 (-8.2%) and $97.9 million in FY2023.
  • The Q4 2025 figure marks the lowest quarterly Cash from Financing Activities since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Boundless Bio 56.41 Mn 56.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 24,000.00
Dec 31, 2024 113,000.00
Sep 30, 2024 -13,000.00
Jun 30, 2024 90.65 Mn
Mar 31, 2024 -924,000.00
Dec 31, 2023 -1.38 Mn
Sep 30, 2023 -447,000.00
Jun 30, 2023 99.70 Mn
Mar 31, 2023 31,000.00
API Access

Boundless Bio Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BOLD&period=max&api_key=YOUR_API_KEY